Jaime A. Miranda Data-verified

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Biologist

Last publication 2026 Last refreshed 2026-05-02

faculty

6 h-index 14 pubs 115 cited

Biography and Research Information

OverviewAI-generated summary

Jaime A. Miranda is a biologist at the National Center for Toxicological Research. His research focuses on the assessment of chemical mutagens and their effects on genetic material. Miranda has investigated the mutagenic potential of compounds such as Molnupiravir and N-nitrosodimethylamine using advanced sequencing technologies like PacBio and HiFi sequencing. His work utilizes both bacterial and mammalian cell systems, including HepaRG cells and mouse lymphoma L5178Y cells, as well as whole organisms like *Caenorhabditis elegans*.

Miranda's publications explore the application of high-throughput and long-read sequencing for detecting ultra-low-frequency mutations across the genome. This includes assessing *in vivo* chemical mutagenesis and identifying off-target mutations in genome-edited cell populations. He also studies the accumulation of somatic cell mutations in organotypic airway cultures following exposure to mutagens like ethyl methanesulfonate. Miranda has a h-index of 6 and has published 14 papers with 104 citations. Key collaborators include Javier R. Revollo, Page B. McKinzie, Vasily N. Dobrovolsky, and Robert H. Heflich, all from the National Center for Toxicological Research.

Metrics

  • h-index: 6
  • Publications: 14
  • Citations: 115

Selected Publications

  • Mutagenicity of <i>N</i> -nitroso-fluoxetine and <i>N</i> -nitroso-varenicline in human HepaRG cell models (2026)
  • Mutation accumulation following extended exposure of human HepaRG cells to a genotoxic carcinogen (2025)
  • Background Mutation Frequencies in <scp>TK6</scp> and <scp>L5178Y</scp> Cells: Implications for Error‐Corrected Sequencing (2025)
  • Complete genome sequence of cephalosporin and tetracycline-resistant <i>Citrobacter freundii</i> CF51 isolate from a patient with urinary tract infection (2024)
    1 citation DOI OpenAlex
  • Assessment of in vivo chemical mutagenesis by long-read sequencing (2024)
    9 citations DOI OpenAlex
  • Repeat treatment of organotypic airway cultures with ethyl methanesulfonate causes accumulation of somatic cell mutations without expansion of bronchial-carcinoma-specific cancer driver mutations (2024)
    2 citations DOI OpenAlex
  • Whole-Genome Sequence Analysis of Antibiotic Resistance, Virulence, and Plasmid Dynamics in Multidrug-Resistant E. coli Isolates from Imported Shrimp (2024)
    7 citations DOI OpenAlex
  • Evaluating the mutagenicity of N-nitrosodimethylamine in 2D and 3D HepaRG cell cultures using error-corrected next generation sequencing (2024)
    21 citations DOI OpenAlex
  • Unbiased whole genome detection of ultrarare off‐target mutations in genome‐edited cell populations by <scp>HiFi</scp> sequencing (2023)
    6 citations DOI OpenAlex
  • Draft Genome Sequences of 14 Fluoroquinolone-Resistant Escherichia coli Isolates from Imported Shrimp (2023)
    1 citation DOI OpenAlex
  • Evaluation of the mutagenic effects of Molnupiravir and <scp>N4</scp>‐hydroxycytidine in bacterial and mammalian cells by <scp>HiFi</scp> sequencing (2022)
    28 citations DOI OpenAlex
  • Genome‐wide detection of ultralow‐frequency substitution mutations in cultures of mouse lymphoma <scp>L5178Y</scp> cells and <i>Caenorhabditis elegans</i> worms by <scp>PacBio</scp> sequencing (2022)
    11 citations DOI OpenAlex
  • <scp>PacBio</scp> sequencing detects genome‐wide ultra‐low‐frequency substitution mutations resulting from exposure to chemical mutagens (2021)
    15 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

49 Collaborators 6 Institutions 3 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics